Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol with or without esketamine for flexible bronchoscopy discharge readiness
ChiCTR2200060367Phase 4Completed
- Sponsor
- Fujian Provincial Hospital
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine and propofol in pulmonary diseases (3 arms), sponsored by Fujian Provincial Hospital. Primary endpoint: Proportion of patients ready for discharge within 30 minutes postoperatively. Started May 2022; status: completed.
02
Drugs
esketaminepropofol
03
Conditions
pulmonary diseases
Beyond the preview
Go deeper on ChiCTR2200060367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200060367.